584 related articles for article (PubMed ID: 34082655)
1. On demand therapy for Parkinson's disease patients: Opportunities and choices.
Hauser RA; LeWitt PA; Comella CL
Postgrad Med; 2021 Sep; 133(7):721-727. PubMed ID: 34082655
[TBL] [Abstract][Full Text] [Related]
2. A review of intermittent subcutaneous apomorphine injections for the rescue management of motor fluctuations associated with advanced Parkinson's disease.
Chen JJ; Obering C
Clin Ther; 2005 Nov; 27(11):1710-24. PubMed ID: 16368444
[TBL] [Abstract][Full Text] [Related]
3. Motor response to acute dopaminergic challenge with apomorphine and levodopa in Parkinson's disease: implications for the pathogenesis of the on-off phenomenon.
Colosimo C; Merello M; Hughes AJ; Sieradzan K; Lees AJ
J Neurol Neurosurg Psychiatry; 1996 Jun; 60(6):634-7. PubMed ID: 8648329
[TBL] [Abstract][Full Text] [Related]
4. The need for non-oral therapy in Parkinson's disease; a potential role for apomorphine.
van Laar T; Borgemeester R
Parkinsonism Relat Disord; 2016 Dec; 33 Suppl 1():S22-S27. PubMed ID: 27998652
[TBL] [Abstract][Full Text] [Related]
5. [Proposed alternative to standard apomorphine challenge test].
Martínez-Castrillo JC; Burguera JA
Rev Neurol; 2012; 55 Suppl 1():S11-3. PubMed ID: 23169227
[TBL] [Abstract][Full Text] [Related]
6. Drugs for Parkinson's disease.
Treat Guidel Med Lett; 2013 Nov; 11(135):101-6. PubMed ID: 24165688
[TBL] [Abstract][Full Text] [Related]
7. New dopaminergic therapies for PD motor complications.
Larson D; Simuni T
Neuropharmacology; 2022 Feb; 204():108869. PubMed ID: 34742740
[TBL] [Abstract][Full Text] [Related]
8. Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review.
Wirdefeldt K; Odin P; Nyholm D
CNS Drugs; 2016 May; 30(5):381-404. PubMed ID: 27138916
[TBL] [Abstract][Full Text] [Related]
9. Contemporary Options for the Management of Motor Complications in Parkinson's Disease: Updated Clinical Review.
Cabreira V; Soares-da-Silva P; Massano J
Drugs; 2019 Apr; 79(6):593-608. PubMed ID: 30905034
[TBL] [Abstract][Full Text] [Related]
10. Apomorphine in the treatment of Parkinson's disease: a review.
Pessoa RR; Moro A; Munhoz RP; Teive HAG; Lees AJ
Arq Neuropsiquiatr; 2018 Dec; 76(12):840-848. PubMed ID: 30698208
[TBL] [Abstract][Full Text] [Related]
11. Subcutaneous apomorphine : an evidence-based review of its use in Parkinson's disease.
Deleu D; Hanssens Y; Northway MG
Drugs Aging; 2004; 21(11):687-709. PubMed ID: 15323576
[TBL] [Abstract][Full Text] [Related]
12. Levodopa Inhalation Powder: A Review in Parkinson's Disease.
Paik J
Drugs; 2020 Jun; 80(8):821-828. PubMed ID: 32319076
[TBL] [Abstract][Full Text] [Related]
13. Current Practices for Outpatient Initiation of Levodopa-Carbidopa Intestinal Gel for Management of Advanced Parkinson's Disease in the United States.
Amjad F; Bhatti D; Davis TL; Oguh O; Pahwa R; Kukreja P; Zamudio J; Metman LV
Adv Ther; 2019 Sep; 36(9):2233-2246. PubMed ID: 31278691
[TBL] [Abstract][Full Text] [Related]
14. [Treatment possibilities in advanced Parkinson's disease].
Takáts A; Nagy H; Radics P; Tóth A; Tamás G
Ideggyogy Sz; 2013 Nov; 66(11-12):365-71. PubMed ID: 24555235
[TBL] [Abstract][Full Text] [Related]
15. Use of advanced therapies for Parkinson's disease in Norway.
Ezat B; Pihlstrøm L; Aasly J; Tysnes OB; Egge A; Dietrichs E
Tidsskr Nor Laegeforen; 2017 May; 137(9):619-623. PubMed ID: 28468476
[TBL] [Abstract][Full Text] [Related]
16. Intranasal apomorphine rescue therapy for parkinsonian "off" periods.
Dewey RB; Maraganore DM; Ahlskog JE; Matsumoto JY
Clin Neuropharmacol; 1996 Jun; 19(3):193-201. PubMed ID: 8726538
[TBL] [Abstract][Full Text] [Related]
17. The cost-effectiveness of levodopa/carbidopa intestinal gel compared to standard care in advanced Parkinson's disease.
Lowin J; Sail K; Baj R; Jalundhwala YJ; Marshall TS; Konwea H; Chaudhuri KR
J Med Econ; 2017 Nov; 20(11):1207-1215. PubMed ID: 28895769
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Parkinson's disease in the advanced stage.
Ossig C; Reichmann H
J Neural Transm (Vienna); 2013 Apr; 120(4):523-9. PubMed ID: 23474822
[TBL] [Abstract][Full Text] [Related]
19. [Inhaled levodopa: from evidence to experience].
Martínez-Castrillo JC; Pareés-Moreno I; López Sendón-Moreno JL; Pérez-Torre P; Fanjul S; Patiño-Patón A; García-Ribas G; Alonso-Cánovas A
Rev Neurol; 2024 Jun; 78(S01):S1-S10. PubMed ID: 38916176
[TBL] [Abstract][Full Text] [Related]
20. [Subcutaneous continuous apomorphine infusion: treatment initiation and follow up].
Grandas FJ; Sesar-Ignacio Á
Rev Neurol; 2012; 55 Suppl 1():S21-4. PubMed ID: 23169229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
